The Recall Desk

Manufacturer

Sun Pharmaceutical Industries Ltd.

1 recall in our database name Sun Pharmaceutical Industries Ltd. as the manufacturing or recalling firm.

What the numbers show

Total
1
Critical
0
Severe
0
Most recent
2023-05-03

Of the 1 recalls from Sun Pharmaceutical Industries Ltd. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–1 of 1

  • HighFDA (Drugs)·D-0569-2023·2023-05-03

    Fyremadel Ganirelix Acetate Injection Recalled for Glass Contamination

    Sun Pharmaceutical is recalling 24,194 prefilled syringes of Fyremadel (ganirelix acetate) injection due to glass contamination found in a unit from lot HAD1190A. The recall affects units distributed nationwide with expiration 02/2024.

    Product
    FYREMADEL — FYREMADEL (GANIRELIX ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide